US20140357643A1 - Derivatives of Betulin - Google Patents

Derivatives of Betulin Download PDF

Info

Publication number
US20140357643A1
US20140357643A1 US14/461,731 US201414461731A US2014357643A1 US 20140357643 A1 US20140357643 A1 US 20140357643A1 US 201414461731 A US201414461731 A US 201414461731A US 2014357643 A1 US2014357643 A1 US 2014357643A1
Authority
US
United States
Prior art keywords
11a
5a
5b
3a
yl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/461,731
Inventor
Brian Alvin Johns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201161576448P priority Critical
Priority to US13/714,627 priority patent/US9102685B2/en
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Priority to US14/461,731 priority patent/US20140357643A1/en
Assigned to GLAXOSMITHKLINE LLC reassignment GLAXOSMITHKLINE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HATCHER, Mark Andrew, JOHNS, BRIAN ALVIN, MARTIN, MICHAEL TOLAR, TABET, Elie Amine, TANG, JUN
Assigned to GLAXOSMITHKLINE LLC reassignment GLAXOSMITHKLINE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HATCHER, Mark Andrew, JOHNS, BRIAN ALVIN, MARTIN, MICHAEL TOLAR, TABET, Elie Amine, TANG, JUN
Publication of US20140357643A1 publication Critical patent/US20140357643A1/en
Application status is Abandoned legal-status Critical

Links